Novartis says ‘all options’ on table for Sandoz generics unit
Shadow loss: Young adults cope with missing out during pandemic
26 October 2021Dragging your feet? Lack of sleep affects your walk, new study finds
26 October 2021Novartis says ‘all options’ on table for Sandoz generics unit
Swiss drugmaker Novartis said Tuesday that it is reviewing the future of its generic medicines division, Sandoz, with all options on the table—from retaining it to a sale.
